Skip to content

Shoulder luminal injection of ropivacaine versus brachial plexus block for postoperative analgesia after arthroscopic shoulder surgery: a randomized clinical trial

Shoulder luminal injection of ropivacaine versus brachial plexus block for postoperative analgesia after arthroscopic shoulder surgery: a randomized clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200061290
Enrollment
Unknown
Registered
2022-06-19
Start date
2022-06-06
Completion date
Unknown
Last updated
2023-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain after arthroscopic shoulder surgery

Interventions

Group 1:Injection of local anesthetic into the shoulder joint
Group 2:0.5% ropivacaine 5 ml brachial plexus block combined with local anesthetic injection into the shoulder joint cavity
Group 3:1% ropivacaine 5 ml brachial plexus block combined with local anesthetic injection into the shoulder joint cavity

Sponsors

Fuyang People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Sign the informed consent; 2. Age 20-65 years old; 3. ASA grade I-III; 4. Patients who plan to undergo elective shoulder arthroscopic surgery.

Exclusion criteria

Exclusion criteria: 1. Severe cardiopulmonary disease, poorly controlled diabetes; 2. Those who have contraindications to the regional block technique (nervous disorders, diaphragm paralysis, allergies to local anesthetics, infection around the puncture site, and coagulation disorders); 3. There is a history of painkiller dependence; systemic steroid use, any chronic pain, chronic opioid use; 4. Mental disorders, dementia patients or severe cognitive impairment; 5. Any cerebrovascular accident occurred within 3 months, such as stroke, transient ischemic attack (TIA), etc.; 6. Patients with severe hypertension or unstable preoperative blood pressure control; 7. Anyone who has difficulty in communication cannot understand the pain score; 8. Severely obese patients with short neck (BMI > 35 kg/m2); 9. Previous shoulder surgery, brachial plexus injury.

Design outcomes

Primary

MeasureTime frame
The time of first pressing analgesic pump after operation;Postoperative resting pain score;Postoperative motion pain score;Postoperative analgesic drug dosage;48-hour satisfaction;

Countries

China

Contacts

Public ContactNiu Yong

Fuyang People's Hospital

449214159@qq.com+86 15956840690

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026